Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Checkmate Pharmaceuticals stock (CMPI)

Buy Checkmate Pharmaceuticals stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Checkmate Pharmaceuticals is a biotechnology business based in the US. Checkmate Pharmaceuticals shares (CMPI) are listed on the NASDAQ and all prices are listed in US Dollars. Checkmate Pharmaceuticals employs 30 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Checkmate Pharmaceuticals stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Complimentary access to a financial planner

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

How to buy Checkmate Pharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CMPI. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Checkmate Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Robinhood
Finder Score: 4.5 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Checkmate Pharmaceuticals stock price (NASDAQ: CMPI)

Use our graph to track the performance of CMPI stocks over time.

Checkmate Pharmaceuticals shares at a glance

Information last updated 2024-01-24.
52-week range$0.00 - $0.00
50-day moving average $8.60
200-day moving average $4.78
Wall St. target price$12.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.92

Is it a good time to buy Checkmate Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Checkmate Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -42.31%
Return on equity TTM -75.44%
Profit margin 0%
Book value $2.54
Market Capitalization $231.4 million

TTM: trailing 12 months

Checkmate Pharmaceuticals share dividends

We're not expecting Checkmate Pharmaceuticals to pay a dividend over the next 12 months.

Checkmate Pharmaceuticals overview

Checkmate Pharmaceuticals, Inc. , a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc.

Frequently asked questions

null
What percentage of Checkmate Pharmaceuticals is owned by insiders or institutions?
Currently 4.633% of Checkmate Pharmaceuticals shares are held by insiders and 77.512% by institutions.
How many people work for Checkmate Pharmaceuticals?
Latest data suggests 30 work at Checkmate Pharmaceuticals.
When does the fiscal year end for Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals's fiscal year ends in December.
Where is Checkmate Pharmaceuticals based?
Checkmate Pharmaceuticals's address is: 245 Main Street, Cambridge, MA, United States, 02142
What is Checkmate Pharmaceuticals's ISIN number?
Checkmate Pharmaceuticals's international securities identification number is: US1628181083

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site